Gender specific LRP5 influences on trabecular bone structure and strength

Journal of Musculoskeletal Neuronal Interactions

Volumn 7, Issue 2, 2007, Pages 166-173

  Dubrow, S A ^a   Hruby, P M ^a   Akhter, M P ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone; Femur; LRP5; Stiffness; Stress; Vertebral body

Indexed keywords

GUANINE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; VALINE;

AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MASS; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; EX VIVO STUDY; FEMALE; FEMUR; FEMUR NECK; GENE MUTATION; GENOTYPE; LUMBAR VERTEBRA; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PROTEIN EXPRESSION; SEX DIFFERENCE; THICKNESS; TRABECULAR BONE; TRANSGENIC MOUSE;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE REGENERATION; COMPRESSIVE STRENGTH; FEMALE; FEMUR; LDL-RECEPTOR RELATED PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; SEX CHARACTERISTICS; SPINE; STRESS, MECHANICAL; TOMOGRAPHY, X-RAY COMPUTED; WEIGHT-BEARING;

EID: 34547868540     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Office of the Surgeon General. Bone health and osteoporosis: A report of the Surgeon General. USA: U.S. Dept of Health and Human Services; 2004. Report No 1.
2. Chrischilles EA, Butler CD, Davis CS, Wallace RB. A model of lifetime osteoporosis impact. Arch Intern Med 1991; 151:2026-2032.
3. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359:1761-1767.
4. Riggs BL, Melton LJ III. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995; 17(Suppl.5):505S-511S.
5. Ralston SH. Genetic determinants of osteoporosis. Curr Opin Rheumatol 2005; 17:475-479.
6. Recker RR. Genetic research in osteoporosis: Where are we? Where should we go next? J Musculoskelet Neuronal Interact 2004; 4:86-90.
7. Seeman E, Hopper JL. Genetic and environmental components of the population variance in bone density. Osteoporos Int 1997; 7(Suppl.3):S10-16.
8. Shen H, Reeker RR, Deng HW. Molecular and genetic mechanisms of osteoporosis: Implication for treatment. Curr Mol Med 2003; 3:737-757.
9. Zmuda JM, Cauley JA, Ferrell RE. Recent progress in understanding the genetic susceptibility to osteoporosis. Genet Epidemiol 1999; 16:356-367.
10. Sawakami K, Robling AG, Ai M, Pitner ND, Liu D, Warden SJ, Li J, Mave P, Rowe DW, Duncan RL, Warman ML, Turner CH. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem 2006; 281:23698-23711
11. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Sauter L, Babi JP, Brown EL, Hill AA, Akhter MP, Johnson ML, Recker RR, Komm BS, Bex FJ. Wnt/b-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 2006; 281:31720-31728.
12. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002; 70:11-19.
13. Patel MS, Karsenty G. Regulation of bone formation and vision by LRP5. N Engl J Med 2002; 346:1572-1574.
14. Mizuguchi T, Furuta I, Watanabe Y, Tsukamoto K, Tomita H, Tsujihata M, Ohta T, Kishino T, Matsumoto N, Minakami H, Niikawa N, Yoshiura K. LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J Hum Genet 2004; 49:80-86.
15. Whyte MP, Remus WH, Mumm S. High-bone-mass disease and LRP5. N Engl J Med 2004; 350:2096-2099.
16. Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, Zheng J, Li L, Harris S, Wu D. The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with mesd. Mol Cell Biol 2004; 24:4677-4684.
17. Rawadi G, Roman Roman S. Wnt signalling pathway: a new target for the treatment of osteoporosis. Expert Opin Ther Targets 2005; 9:1063-1077.
18. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 2004; 74:866-875.
19. Johnson ML. The high bone mass family - the role of Wnt/Lrp5 signaling in the regulation of bone mass. J Musculoskelet Neuronal Interact 2004; 4:135-138.
20. Bollerslev J, Wilson SO, Dick IM, Islam FM, Ueland T, Palmer L, Devine A, Prince RL. LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 2005; 36:599-606.
21. Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, Conneally PM, Hui SL, Johnston CC, Peacock M, Foroud T, Econs MJ. Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 2005; 20:75-80.
22. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 2003; 18:960-974.
23. Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babij P, Allen KM, Yaworsky PJ, Bex F, Recker RR. Bone biomechanical properties in LRP5 mutant mice. Bone 2004; 35:162-169.
24. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 2003; 72:763-771.
25. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA, 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt co-receptor. J Cell Biol 2002; 157:303-314.
26. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene 2004; 341:19-39.
27. Clement Lacroix P, Ai M, Morvan F, Roman Roman S, Vayssiere B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G. LRP5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 2005; 102:17406-17411.
28. Glass DA II, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005; 8:751-764.
29. Turner CH, Hsieh YF, Muller R, Bouxsein ML, Baylink DJ, Rosen CJ, Grynpas MD, Donahue LR, Beamer WG. Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res 2000; 15:1126-1131.
30. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone 1996; 18:397-403.
31. Johnson ML, Harnish K, Nusse R, Van Hul W. LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res 2004; 19:1749-1757.
32. Cullen DM, Akhter MP, Johnson ML, Morgan S, Recker RR. Ulna loading response altered by the HBM mutation. J Bone Miner Res 2004; 19(Suppl.1):S396.
33. Jiang Y, Zhao J, Liao EY, Dai RC, Wu XP, Genant HK. Application of micro-CT assessment of 3-D bone microstructure in preclinical and clinical studies. J Bone Miner Metab 2005; 23(Suppl.):122-131.
34. Akhter MP, Iwaniec UT, Covey MA, Cullen DM, Kimmel DB, Recker RR. Genetic variations in bone density, histomorphometry, and strength in mice. Calcif Tissue Int 2000; 67:337-344.
35. Kang Q, An YH, Friedman RJ. Effects of multiple freezing-thawing cycles on ultimate indentation load and stiffness of bovine cancellous bone. Am J Vet Res 1997; 58:1171-1173.
36. Bex F, Green J, Marzolf J, Babij P, Yaworsky PJ, Kharode Y. The human LRP5 G171V mutation in mice alters the skeletal response to limb unloading but not to ovariectomy. J Bone Miner Res 2003; 18(Suppl.1):S60.
37. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA. Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002; 277:30998-31004.
38. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, Kato S. Wnt/beta-catenin and estrogen signaling converge in vivo. J Biol Chem 2004; 279:40255-40258.
39. Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME. Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J Biol Chem 2002; 277:20702-20710.
40. Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z. Linking beta-catenin to androgen-signaling pathway. J Biol Chem 2002; 277:11336-11344.
41. Akhter MP, Fan Z, Rho JY. Bone intrinsic material properties in three inbred mouse strains. Calcif Tissue Int 2004; 75:416-420.